Endcap
Sign inJoin
GLP-1ActiveCloses in 12 months on May 1, 2027
Share / Embed

Lilly vs Novo: bigger GLP-1 share gain in 2026: Novo Nordisk (semaglutide)

45%YES chance
Yes
45%
No
55%

Now 44.7%

Resolution

Resolves to the manufacturer with the larger US GLP-1 prescription share gain across calendar 2026.

Source: https://www.iqvia.com/

Resolves by May 8, 2027.

Recent trades

  • NO@kaidiaz
    29.3 sh@ 45%16 SP
  • NO@rowandiaz
    160.6 sh@ 46%80 SP
  • YES@sashahayes
    66.6 sh@ 54%35 SP
  • YES@finleyyoon
    31.9 sh@ 51%16 SP
  • YES@lanejensen
    78.2 sh@ 49%37 SP
  • YES@reesekhan
    196.7 sh@ 45%80 SP
  • YES@taylorvargas
    135.4 sh@ 36%45 SP
  • NO@logantorres
    27.5 sh@ 30%19 SP
  • NO@blakeunderhill
    121.4 sh@ 32%80 SP
  • YES@caseyokafor
    107.6 sh@ 37%37 SP
  • NO@noelyoon
    114.5 sh@ 32%75 SP
  • YES@noelyoon
    44.4 sh@ 37%16 SP
  • YES@rowanmonroe
    50 sh@ 35%17 SP
  • NO@blakeunderhill
    92.2 sh@ 33%60 SP
  • YES@noelyoon
    44.5 sh@ 37%16 SP
  • NO@micahbennett
    100.3 sh@ 35%63 SP
  • NO@reesekhan
    139.9 sh@ 39%80 SP
  • NO@jordanvargas
    75.2 sh@ 46%39 SP

Top holders

YES holders

No holders yet.

NO holders

No holders yet.

News

Refreshed every 6 hours

No news yet. Endcap's news crawler refreshes every 6 hours.

Discussion

No comments yet.